Results 91 to 100 of about 838,109 (163)

First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies. [PDF]

open access: yesJ Immunother Cancer
Naing A   +15 more
europepmc   +1 more source

Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response. [PDF]

open access: yesJ Immunother Cancer
Shim D   +8 more
europepmc   +1 more source

Exploring the acceptability of a brief, rapid-access, self-harm focussed talking therapy: a qualitative analysis of patient experiences. [PDF]

open access: yesBMJ Open
Clements C   +9 more
europepmc   +1 more source

Impact of COVID-19 pandemic on autism spectrum disorder service providers in Qatar: challenges, insights, and lessons learned. [PDF]

open access: yesFront Psychiatry
Alshaban F   +9 more
europepmc   +1 more source

Error in Figure.

open access: yesJAMA Otolaryngol Head Neck Surg
europepmc   +1 more source

Home - About - Disclaimer - Privacy